GYPA and transient ischemic attack: While we have observed that erythrocyte-derided EVs (CD235a+) were increased to the same extent in both TIA and AIS compared to controls within 48 h of onset of attacks, we found that their levels, expressed as a proportion of onset levels, decreased in both TIA and AIS patients at 5- and 30-days following the initiation of pharmacotherapy.